RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM)

CUSIP: 76243J105

Q3 2021 13F Holders as of 30 Sep 2021

Security identity
Shares outstanding
69,012,275
Holder snapshot
Share change
+472,605
Put/Call ratio
0%
Reported price per share
$13.06
Number of holders
93
Value change
+$2,428,146
Number of buys
35
Number of sells
45

Security key

76243J105

Report period

Q3 2021

Institutions

93

Top holders

10

Ownership snapshot

Top reported holders of RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
PRIMECAP MANAGEMENT CO/CA/
13D/G signal
Evidence rows
15
Latest as of
30 Jun 2021
13F Lead comparable stake: 8.9% Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
8.9%
$120,489,000
6,153,691 shares
30 Jun 2021
NEA Management Company, LLC
13F
Company
13F
7.1%
$96,183,000
4,912,306 shares
30 Jun 2021
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
7.1%
$71,077,000
4,871,067 shares
30 Jun 2021
JANUS HENDERSON GROUP PLC
13F
Company
13F
5.7%
$76,872,000
3,926,050 shares
30 Jun 2021
BAKER BROS. ADVISORS LP
13F
Company
13F
5.6%
$75,642,000
3,863,239 shares
30 Jun 2021
BlackRock Finance, Inc.
13F
Company
13F
4.8%
$65,311,000
3,335,661 shares
30 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
93
Shares
47,950,622
Rows available
93
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
101
Q3 2021 holders
93
Holder diff
-8
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .